Putative Involvement of Cytokine Modulation in the Development of Perioperative Neurocognitive Disorders
Christopher Pereira,Melanie Dani,Simon D Taylor-Robinson,Michael Fertleman
DOI: https://doi.org/10.2147/IJGM.S364954
IF: 2.145
2022-06-01
International Journal of General Medicine
Abstract:Christopher Pereira, 1 Melanie Dani, 1 Simon D Taylor-Robinson, 2 Michael Fertleman 1 1 Cutrale Perioperative and Ageing Group, Department of Bioengineering, Imperial College London, London, UK; 2 Department of Surgery and Cancer, Imperial College London, London, UK Correspondence: Michael Fertleman, Cutrale Perioperative and Ageing Group, Department of Bioengineering, Imperial College London, London, UK, Tel +44 203 312 1077, Email Following surgery, local cytokine-driven inflammation occurs, as part of the normal healing process. Cytokines in the central nervous system such as IL-6 and IL-8 may also be elevated. These cytokine changes likely contribute to neuroinflammation, but the complex mechanisms through which this occurs are incompletely understood. It may be that perioperative changes in pro- and anti-inflammatory cytokines have a role in the development of perioperative neurocognitive disorders (PND), such as post-operative delirium (POD). This review considers the current evidence regarding perioperative cytokine changes in the blood and cerebrospinal fluid (CSF), as well as considering the potential for cytokine-altering therapies to prevent and treat PND. Keywords: neuroinflammation, interleukins, central nervous system, perioperative neurocognitive disorders, blood-brain barrier, delirium There is a growing appreciation that a peripheral insult to the body, such as surgery, can lead to cytokine-driven inflammation in the central nervous system (CNS). 1,2 This may be a key factor in the development of perioperative neurocognitive disorders (PND), such as delirium. 3 However, the mechanisms through which neuroinflammation occurs are currently unclear. 4 Neuroinflammation is an inflammatory response within the brain or spinal cord that is partly mediated by cytokines. 5 In the CNS, the predominant immune cells are the microglia, which are seen as the key driver of neuroinflammation, partly through release of intracerebral cytokines. 6 Microglia have historically been considered to be either in the M1 (pro-inflammatory and injurious) or M2 (anti-inflammatory and protective) state. 7,8 The M1 phenotype is activated by lipopolysaccharides (LPS) and the pro-inflammatory cytokine IFN-γ, leading to the production of oxidative metabolites, proteases and pro-inflammatory cytokines such as IL‐1β, IL‐6 and TNF-α. 9,10 The M2 phenotype is activated by anti-inflammatory cytokines such as IL-4 and IL-13, and results in tissue repair and angiogenesis via arginase 1 and anti-inflammatory cytokines such as IL-10. 9 While the M1 versus M2 phenotype is a useful classification, there is now an appreciation that the reality is likely to be more complex, with intermediate microglia states, rather than a clear binary role. 8,11,12 The role of activated microglia is to guard against pathogens and tumour cells, so serving a key protective role in the brain. 9 However, chronically activated microglia have been shown to release toxic factors such as cytokines and reactive oxygen species, which drive neuronal damage seen in many neurodegenerative diseases, such as Alzheimer's disease. 13 We hypothesise that this may also be a contributor to perioperative neurocognitive disorders. PND is an umbrella term that includes cognitive impairment acutely after surgery (post-operative delirium), up to 30-days after surgery (delayed neurocognitive recovery) and up to 12-months after surgery (post-operative neurocognitive disorder). 14 The commonest surgical complication in older people is post-operative delirium (POD), which affects around a quarter of patients admitted with hip fracture. 15 The impact of delirium can be devastating and is distressing for patients, relatives and staff. 2,16 Delirium is associated with an increase in mortality 17–19 and poor functional recovery. 20 Furthermore, delirium has been shown to be an independent risk factor for developing dementia. 21 Understanding and treating PND is more important than ever with an ageing population. 22,23 It is unknown whether PND arises from anaesthesia, surgery or both. 1 Studies have shown that rates of PND are not affected by the type of anaesthesia used, possibly suggesting that the surgery, rather than the anaesthesia, drives PND. 14,24 However, whether it is surgery or anaesthesia driving the process, there are currently no licensed drugs to prevent or treat PND, beyond trying to minimise the excessive use of sedation or analgesia. 4 Cytokine-altering therapy offers a possible way of treating and preventing PND. The role of neuroinflammation has been increasingly studied in neurodegenerative -Abstract Truncated-
medicine, general & internal